Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01392846
Other study ID # CVRF2011-07
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2011
Est. completion date March 2, 2020

Study information

Verified date September 2021
Source CardioVascular Research Foundation, Korea
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective, observational, cohort study to evaluate the relative efficacy and safety of Resolute Integrity stent compared to other (drug eluting stents) DES.


Description:

Consecutive Percutaneous Coronary Intervention patients receiving Resolute Integrity stent will be compared with other concurrent Drug Eluting Stents.


Recruitment information / eligibility

Status Completed
Enrollment 3000
Est. completion date March 2, 2020
Est. primary completion date January 20, 2016
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with significant coronary artery disease and receiving Resolute Integrity stent. - The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site. Exclusion Criteria: - Patients with a mixture of other DESs - Terminal illness with life expectancy <1 year - Patients presented with cardiogenic shock

Study Design


Locations

Country Name City State
Korea, Republic of Hallym University Sacred Heart Hospital Anyang
Korea, Republic of Soon Chun Hyang University Hospital Bucheon Bucheon
Korea, Republic of The Catholic University of Korea, Bucheon ST.Mary's Hospital Bucheon
Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan
Korea, Republic of Daegu Catholic University Medical Center Daegu
Korea, Republic of Kyungpook National University Hospital Daegu
Korea, Republic of Yeungnam University Medical Center Daegu
Korea, Republic of The Catholic University of Korea, Daejeon ST.Mary's Hospital Daejeon
Korea, Republic of Gang Neung Asan Hospital Gangneung
Korea, Republic of Chonnam National University Hospital Gwangju
Korea, Republic of Inje University Ilsan Paik Hospital Ilsan Gyeong-gi
Korea, Republic of National Health Insurance Corporation Ilsan Hospital Ilsan
Korea, Republic of Gachon University Gil Hospital Incheon
Korea, Republic of Presbyterian Medical Center Jeonju
Korea, Republic of Kwangju Christian Hospital Kwangju
Korea, Republic of Pusan National University Yangsan Hospital Pusan
Korea, Republic of Asan Medical Center Seoul
Korea, Republic of Gangnam Severance Hospital Seoul
Korea, Republic of Kangdong Sacred Heart Hospital Seoul
Korea, Republic of Korea University Guro Hospital Seoul
Korea, Republic of St.carollo Hospital Suncheon
Korea, Republic of The Catholic University of Korea Uijeongbu St. Mary's Hospital Uijeongbu
Korea, Republic of Ulsan University Hospital Ulsan

Sponsors (3)

Lead Sponsor Collaborator
Seung-Jung Park CardioVascular Research Foundation, Korea, Medtronic

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary composite of death, nonfatal myocardial infarction (MI), or target- Vessel Revascularization (TVR) 12 months post procedure
Secondary Death (all cause and cardiac) one month
Secondary Death (all cause and cardiac) 6 months
Secondary Death (all cause and cardiac) 12 months and yearly up to 5 years
Secondary Myocardial Infarction one month
Secondary Myocardial Infarction 6 months
Secondary Myocardial Infarction 12 months and yearly upto 5 years
Secondary Composite of death or MI one month
Secondary Composite of death or MI 6 months
Secondary Composite of death or MI 12 months and yearly upto 5 years
Secondary Composite of cardiac death or MI one month
Secondary Composite of cardiac death or MI 6 months
Secondary Composite of cardiac death or MI 12 months and yearly up to 5 years
Secondary Target Vessel Revascularization one month
Secondary Target Vessel Revascularization 6 months
Secondary Target Vessel Revascularization 12 months and yearly up to 5 years
Secondary Target-lesion revascularization one month
Secondary Target-lesion revascularization 6 months
Secondary Target-lesion revascularization 12 months and yearly up to 5 years
Secondary Stent thrombosis one month
Secondary Stent thrombosis 6 months
Secondary Stent thrombosis 12 months and yearly up to 5 years
Secondary Stroke 12 months and yearly up to 5 years
Secondary Procedural success It is defined as achievement of a final diameter stenosis of <30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization. at day 1
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A